Equibles does not estimate personal net worth.
Get an email with a short summary when Lifecore Biomedical, Inc. De publishes a filing, an earnings call transcript or a press release.
Get LFCR alertsRyan Lake is recorded as CFO at Lifecore Biomedical, Inc. De (LFCR). Ryan Lake has spoken on 6 earnings calls across 1 company, most recently for Lifecore Biomedical, Inc. De on August 5, 2026. Lifecore Biomedical, Inc. De is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Lifecore Biomedical, Inc. De includes Paul Josephs (CEO and Board Member), Craig A. Barbarosh (Chairman), Katrina L. Houde (Chairman and Board Member) and 7 others.
“In conjunction with my comments, I'd like to recommend that participants refer to Life Corps' Form 10-Q filing, which we filed with the SEC this morning. As a reminder, we will be comparing our results for the second quarter ended June 30, 2026, with the comparable prior year quarter ended May 25, 2025.”
“In conjunction with my comments, I'd like to recommend that participants refer to LifeCourse Form 10-Q filing, which we filed with the SEC earlier today. As a reminder, today we will compare our first quarter, which ended on March 31, 2026, with the comparable prior year quarter ending on February 23, 2025.”
“In conjunction with my comments, I'd like to recommend that participants refer to Life Corps' Form 10-KT for the transition period ended December 31st, 2025, which we filed with the SEC earlier today.”
“In connection with my comments, I'd like to recommend that participants refer to LifeCourse Form 10 filing with the Securities and Exchange Commission, which we filed today.”
“In conjunction with my comments, I would like to recommend that participants refer to our filings with the Securities and Exchange Commission, which we filed today.”
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
